04/10/2024
8:45 AM | Biomea Fusion (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
03/28/2024
3:05 PM | Biomea Fusion (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
4:00 PM | Biomea Fusion (Subject)
Erdtmann Rainer M (Filed by)
| Form SC 13G/A | |
02/12/2024
4:00 PM | Biomea Fusion (Subject)
Butler Thomas Andrew (Filed by)
| Form SC 13G/A | |
02/12/2024
11:58 AM | Biomea Fusion (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Biomea Fusion (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
11:29 AM | Biomea Fusion (Subject)
Laurion Capital Management LP (Filed by)
| Form SC 13G | |
|
01/29/2024
4:25 PM | Biomea Fusion (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/18/2024
3:30 PM | Biomea Fusion (Issuer)
Frias Juan Pablo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:30 PM | Biomea Fusion (Issuer)
Valle Franco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:30 PM | Biomea Fusion (Issuer)
Erdtmann Rainer M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:30 PM | Biomea Fusion (Issuer)
Butler Thomas Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:06 PM | Biomea Fusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
3:30 PM | Biomea Fusion (Issuer)
Erdtmann Rainer M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:58 PM | Biomea Fusion (Issuer)
Valle Franco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2023
3:30 PM | Biomea Fusion (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2023
3:05 PM | Biomea Fusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
4:00 PM | Biomea Fusion (Issuer)
Frias Juan Pablo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/01/2023
4:10 PM | Biomea Fusion (Issuer)
Frias Juan Pablo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
3:12 PM | Biomea Fusion (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:12 PM | Biomea Fusion (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:08 PM | Biomea Fusion (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:00 PM | AGUIAR ERIC (Reporting)
Biomea Fusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:00 PM | Biomea Fusion (Issuer)
Ray Sumita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:02 PM | Biomea Fusion (Issuer)
Faust Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:03 PM | Biomea Fusion (Issuer)
Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Cormorant Private Healthcare Fund III LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:06 PM | Biomea Fusion (Issuer)
Hitchcock Michael J.M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
6:13 AM | A2A Pharmaceuticals, Inc. (Reporting)
Biomea Fusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
4:19 PM | A2A Pharmaceuticals, Inc. (Reporting)
Biomea Fusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2023
8:45 AM | Biomea Fusion (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
04/28/2023
3:10 PM | Biomea Fusion (Filer)
| Form ARS | |
04/27/2023
9:28 AM | A2A Pharmaceuticals, Inc. (Reporting)
Biomea Fusion (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2023
7:36 AM | A2A Pharmaceuticals, Inc. (Reporting)
Biomea Fusion (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
